Your browser doesn't support javascript.
loading
Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
Gupta, Santosh; Hovelson, Daniel H; Kemeny, Gabor; Halabi, Susan; Foo, Wen-Chi; Anand, Monika; Somarelli, Jason A; Tomlins, Scott A; Antonarakis, Emmanuel S; Luo, Jun; Dittamore, Ryan V; George, Daniel J; Rothwell, Colin; Nanus, David M; Armstrong, Andrew J; Gregory, Simon G.
Afiliación
  • Gupta S; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Hovelson DH; Duke Molecular Physiology Institute, Duke University, Durham, North Carolina.
  • Kemeny G; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
  • Halabi S; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Foo WC; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina.
  • Anand M; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Somarelli JA; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Tomlins SA; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Antonarakis ES; Department of Medicine, Surgery, Pharmacology and Cancer Biology, Duke University, Durham, North Carolina.
  • Luo J; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
  • Dittamore RV; Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • George DJ; James Buchanan Brady Urological Institute and the Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Rothwell C; Epic Sciences, La Jolla, California.
  • Nanus DM; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, North Carolina.
  • Gregory SG; Department of Medicine, Weill Cornell Medicine, New York, New York.
Genes Chromosomes Cancer ; 59(4): 225-239, 2020 04.
Article en En | MEDLINE | ID: mdl-31705765
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Variación Genética / Biomarcadores de Tumor / Neoplasias de la Próstata Resistentes a la Castración / ADN Tumoral Circulante / Células Neoplásicas Circulantes Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Genes Chromosomes Cancer Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Variación Genética / Biomarcadores de Tumor / Neoplasias de la Próstata Resistentes a la Castración / ADN Tumoral Circulante / Células Neoplásicas Circulantes Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Genes Chromosomes Cancer Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos